Similarly, 28 ESCC patients were categorized into two groups based on the protein expression of ILF3: the one group (Group IV) included 16 patients with a higher ILF3 expression in tumor tissues than the para-tumor tissues; the other group (Group III) consisted of the remaining 12 patients (Supplementary Figure S1). Here, ILF3 is linked to neoplasm.